DR. ALAN R. HALL M.D. NPI 1093756645

NPI Information

  • NPI: 1093756645
  • Provider Name: DR. ALAN R. HALL, M.D.
  • Classification: Clinic/Center - 261QU0200X
  • Specialization: Urgent Care
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 201 S OAKRIDGE DR
    HUDSON OAKS, TX
    ZIP 76087
  • Phone: (817) 599-5518

Map and Directions

Get Directions

NPI Details

DR. Alan R. Hall, M.D. is an urgent care clinic center in Hudson Oaks, TX with 44 years of experience. DR. Alan R. Hall, M.D. NPI is 1093756645. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF TEXAS MEDICAL SCHOOL AT HOUSTON
Graduation Year:1982

The provider's business location address is:

201 S OAKRIDGE DR
HUDSON OAKS, TX
ZIP 76087-793
Phone: (817) 599-5518
Fax: (817) 599-5538

The NPI 1093756645 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) (HCPCS:87811)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg (HCPCS:J0702)
  • Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Injection, methylprednisolone acetate, 80 mg (HCPCS:J1040)
  • Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected (HCPCS:0241U)
  • New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
  • Detection test by immunoassay with direct visual observation for influenza virus (HCPCS:87804)
  • Manual urinalysis test with examination using microscope, non-automated (HCPCS:81000)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • X-ray of chest, 2 views (HCPCS:71046)
  • Removal of impacted ear wax (HCPCS:69210)
  • Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) (HCPCS:87880)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique (HCPCS:87651)
  • X-ray of foot, minimum of 3 views (HCPCS:73630)
  • Inhalation treatment for airway obstruction or sputum production (HCPCS:94640)
  • Administration of vaccine (HCPCS:90471)
  • Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
  • X-ray of hand, minimum of 3 views (HCPCS:73130)
  • Removal of foreign body from tissue, accessed beneath the skin, simple (HCPCS:10120)
  • Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg (HCPCS:J7613)
  • Diphtheria and tetanus vaccine (7 years or older) (HCPCS:90714)

The enumeration date for this NPI number is 6/8/2006 and was last updated on 8/30/2023.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1261QU0200XClinic/CenterUrgent CareYes
2207Q00000XFamily MedicineG3426TEXASNo

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.